Abstract:Background: The expression and activation of eukaryotic translation initiation factor 4E (eIF4E) is associated with cell transformation and tumor initiation, but the functional role and the mechanism whereby it drives immune cell infiltration in breast cancer (BRCA) remain uncertain. Methods: Oncomine, Timer and UALCAN were used to analyze the expression of eIF4E in various cancers. PrognoScan, Kaplan-Meier plotter, and GEPIA were utilized to analyze the prognostic value of eIF4E in select cancers. In vitro cell experiments were used to verify the role of eIF4E in promoting the progression of BRCA. ImmuCellAI and TIMER database were used to explore the relationship between eIF4E and tumor infiltrating immune cells. The expression of a macrophage marker (CD68+) and an M2-type marker (CD163+) was evaluated using immunohistochemistry in 50 invasive BRCA samples on tissue microarrays. The Human Protein Atlas (HPA) database was used to show the expression of eIF4E and related immune markers. LinkedOmics and NetworkAnalyst were used to build the signaling network. Results: Through multiple dataset mining, we found that the expression of eIF4E in BRCA was higher than that in normal tissues, and patients with increased eIF4E expression had poorer survival and a higher cumulative recurrence rate in BRCA. At the cellular level, BRCA cell migration and invasion were significantly inhibited after eIF4E expression was inhibited by siRNA. Immune infiltration analysis showed that the eIF4E expression level was significantly associated with the tumor purity and immune infiltration levels of different immune cells in BRCA. The results from immunohistochemical (IHC) staining further proved that the expression of CD68+ and CD163+ were significantly increased and correlated with poor prognosis in BRCA patients (P < 0.05). Finally, interaction network and functional enrichment analysis revealed that eIF4E was mainly involved in tumor-related pathways, including the cell adhesion molecule pathway and the JAK-STAT signaling pathway. Conclusions: Our study has demonstrated that eIF4E expression has prognostic value for BRCA patients. eIF4E may act as an essential regulator of tumor macrophage infiltration and may participate in macrophage M2 polarization.

Eif4e Binding Protein 1 Expression is Associated with Clinical Survival Outcomes in Colorectal Cancer

New Insights into the Role of Endoplasmic Reticulum Stress Signaling Protein XBP1 in Tumor Progression

E2F1 Renders Prostate Cancer Cell Resistant to ICAM-1 Mediated Antitumor Immunity by NF-κB Modulation.

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

YY1 Promotes Colorectal Cancer Proliferation Through the Mir-526B-3p/e2f1 Axis.

Elevated Nuclear Phospho-Eif4e Body Levels Are Associated with Tumor Progression and Poor Prognosis for Acute Myeloid Leukemia

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers

Eukaryotic Initiation Factor 4A2 Promotes Experimental Metastasis and Oxaliplatin Resistance in Colorectal Cancer

Depletion of 4E-Bp1 and Regulation of Autophagy Lead to Yxm110-Induced Anticancer Effects

High expression of eIF4A1 predicts unfavorable prognosis in clear cell renal cell carcinoma

Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer

eIF4E S209 phosphorylation licenses Myc-and stress-driven oncogenesis

Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers

Eukaryotic Initiation Factor 4A2 (EIF4A2) Expression in Colorectal Cancer and Prediction of Prognosis.

Retinoblastoma Binding Protein 4 Up-Regulation is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Cancer Patients.

High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer

The role of basic leucine zipper transcription factor E4BP4 in cancer: a review and update

Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy

EYA4 could be an indicator signifying colorectal cancer sufferers' prognoses

Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma